Moving towards personalized treatments of immune-related adverse events.
Nat Rev Clin Oncol. 2020 Aug;17(8):504-515. doi: 10.1038/s41571-020-0352-8. Epub 2020 Apr 3.
Nat Rev Clin Oncol. 2020.
PMID: 32246128
Review.